These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17803034)

  • 1. Coincidence vs cause: cure in three glioblastoma patients treated with brachytherapy.
    Dehdashti AR; Sharma S; Laperriere N; Bernstein M
    Can J Neurol Sci; 2007 Aug; 34(3):339-42. PubMed ID: 17803034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of iodine-125 brachytherapy on the proliferative capacity and histopathological features of glioblastoma recurring after initial therapy.
    Siddiqi SN; Provias J; Laperriere N; Bernstein M
    Neurosurgery; 1997 May; 40(5):910-7; discussion 917-8. PubMed ID: 9149248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachytherapy. Results of two different therapy strategies for patients with primary glioblastoma multiforme.
    Vordermark D
    Cancer; 2001 Mar; 91(6):1185-6. PubMed ID: 11267965
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.
    Sneed PK; Gutin PH; Larson DA; Malec MK; Phillips TL; Prados MD; Scharfen CO; Weaver KA; Wara WM
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):719-27. PubMed ID: 8040017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.
    Patel S; Breneman JC; Warnick RE; Albright RE; Tobler WD; van Loveren HR; Tew JM
    Neurosurgery; 2000 May; 46(5):1123-8; discussion 1128-30. PubMed ID: 10807244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2.
    Gutin PH; Prados MD; Phillips TL; Wara WM; Larson DA; Leibel SA; Sneed PK; Levin VA; Weaver KA; Silver P
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):601-6. PubMed ID: 1651302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double balloon GliaSite in the management of recurrent glioblastoma multiforme.
    Payne JT; St Clair WH; Given CA; Young B; Meigooni A
    South Med J; 2005 Sep; 98(9):957-8. PubMed ID: 16220608
    [No Abstract]   [Full Text] [Related]  

  • 9. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
    Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
    Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?
    Koot RW; Habraken JB; Hulshof MC; Paans AM; Bosch DA; Pruim J
    Acta Neurochir (Wien); 2008 Apr; 150(4):345-9. PubMed ID: 18278573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas.
    Schwartz C; Romagna A; Thon N; Niyazi M; Watson J; Belka C; Tonn JC; Kreth FW; Nachbichler SB
    Acta Neurochir (Wien); 2015 Oct; 157(10):1757-64; discussion 1764. PubMed ID: 26298594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme.
    Sneed PK; Lamborn KR; Larson DA; Prados MD; Malec MK; McDermott MW; Weaver KA; Phillips TL; Wara WM; Gutin PH
    Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):37-44. PubMed ID: 8641924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocurietherapy of glioblastoma multiforme with 125iodine: results of treatment.
    Kumar PP; Good RR; Skultety FM; Leibrock LG
    Radiat Med; 1987; 5(3):94-8. PubMed ID: 2827240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial brachytherapy of malignant gliomas: the Memorial Sloan-Kettering Cancer Center experience.
    Malkin MG
    Recent Results Cancer Res; 1994; 135():117-25. PubMed ID: 8047687
    [No Abstract]   [Full Text] [Related]  

  • 16. Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy.
    Aiken AH; Chang SM; Larson D; Butowski N; Cha S
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1340-6. PubMed ID: 18538496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas.
    Wen PY; Alexander E; Black PM; Fine HA; Riese N; Levin JM; Coleman CN; Loeffler JS
    Cancer; 1994 Jun; 73(12):3029-36. PubMed ID: 8200000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GammaTile
    Gessler DJ; Ferreira C; Dusenbery K; Chen CC
    Future Oncol; 2020 Oct; 16(30):2445-2455. PubMed ID: 32618209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy for malignant recurrent and untreated gliomas.
    Hitchon PW; VanGilder JC; Wen BC; Jani S
    Stereotact Funct Neurosurg; 1992; 59(1-4):174-8. PubMed ID: 1338232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas.
    Leibel SA; Gutin PH; Wara WM; Silver PS; Larson DA; Edwards MS; Lamb SA; Ham B; Weaver KA; Barnett C
    Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1129-39. PubMed ID: 2557303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.